Thermo Fisher Scientific Inc (TMO)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	6,859,000	6,866,000	6,712,000	7,135,000	8,393,000	9,070,000	9,638,000	9,800,000	10,028,000	10,561,000	10,709,000	9,937,000	7,794,000	5,955,000	4,475,000	4,580,000	4,594,000	4,510,000	4,476,000	3,917,000
Revenue (ttm)	US$ in thousands	41,415,000	42,229,000	42,518,000	42,979,000	44,225,000	42,978,000	41,676,000	40,005,000	37,933,000	38,365,000	37,540,000	35,169,000	31,689,000	28,090,000	25,821,000	25,176,000	25,008,000	24,686,000	24,336,000	24,109,000
Operating profit margin		16.56%	16.26%	15.79%	16.60%	18.98%	21.10%	23.13%	24.50%	26.44%	27.53%	28.53%	28.25%	24.60%	21.20%	17.33%	18.19%	18.37%	18.27%	18.39%	16.25%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $6,859,000K ÷ $41,415,000K
= 16.56%

Thermo Fisher Scientific Inc.'s operating profit margin has shown a declining trend over the past eight quarters. The company experienced a decrease in its operating profit margin from 24.28% in Q1 2022 to 17.08% in Q4 2023. This downward trend may indicate increasing costs or lower revenue generation relative to operating expenses. It is important for the company to closely monitor its cost structure and revenue sources to improve its operating profit margin and overall profitability in the future.